| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | +2310.7% |
| SG&A Expense | $2.5M | +194.7% |
| Operating Income | -$3.7M | -313.0% |
| Net Income | -$2.0M | -29.3% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $47K | +130.9% |
| Total Assets | $47K | +130.9% |
| Current Liabilities | $14.1M | +8.5% |
| Stockholders' Equity | -$14.1M | -8.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$710K | -59.9% |
| Financing Cash Flow | $691K | +49.2% |